Instituto de Investigación Sanitaria Gregorio Marañón
University of California, Los Angeles
University of Texas MD Anderson Cancer Center
College of Medicine, Seoul National University
BC Cancer Agency
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ ERBB2 -Negative Early Breast Cancer
Michael Untch, Juan Pablo Zarate, Sherene Loi, Dennis J. Slamon et al.
Citations
12 citations
Journal
JAMA Oncology
Topics
Advanced Breast Cancer Therapies
Field-Weighted Citation Impact (FWCI)
18.22
article
Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ ERBB2 -Negative Early Breast Cancer
Michael Untch, Juan Pablo Zarate, Sherene Loi, Dennis J. Slamon, Gabriel N. Hortobágyi, Chiun‐Sheng Huang, Zheng Li, Sorcha Waters, Aditya Bardia, John Paul Crown, Rodrigo Fresco, DA Yardley, Sara A. Hurvitz, Seock‐Ah Im, Daniil Stroyakovskiy, Stephen Chia, Carlos H. Barrios, Peter A. Fasching, Miguel Martín, Rebecca Moroose, F. Visco
article en
12 citations
Abstract
No abstract available for this paper.
Publication Tag
JAMA OncologyVol. 11(11)
Institutions
BC Cancer Agency (CA), National Coalition for Cancer Survivorship (US), The University of Texas MD Anderson Cancer Center (US), Orlando Health (US), University of California, Los Angeles (US), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), University of Washington (US), Peter MacCallum Cancer Centre (AU), Peking Union Medical College Hospital (CN), Seoul National University Hospital (KR), Fred Hutch Cancer Center (US), Sarah Cannon (US), St. Vincent's University Hospital (IE), Novartis (United States) (US), National Taiwan University Hospital (TW), Comprehensive Cancer Center Erlangen (DE), Novartis (Ireland) (IE), Helios Hospital Berlin-Buch (DE), Centro de Investigación Biomédica en Red de Cáncer (ES), Moscow City Oncology Hospital №62 (RU)
Funders
Cancer Research Institute, University of Washington, Novartis Pharmaceuticals Corporation, Seoul National University, Universidad Complutense de Madrid, Peter MacCallum Cancer Centre, Seoul National University Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Instituto de Investigación Sanitaria Gregorio Marañón, University of California, Los Angeles, University of Texas MD Anderson Cancer Center, College of Medicine, Seoul National University, BC Cancer Agency